In the last trading session, 3.39 million TransCode Therapeutics Inc (NASDAQ:RNAZ) shares changed hands as the company’s beta touched 1.47. With the company’s per share
In recent trading session, TransCode Therapeutics Inc (NASDAQ:RNAZ) saw 1.06 million shares changing hands at last check today with its beta currently measuring 1.53. Company’s
TransCode Therapeutics Inc (NASDAQ:RNAZ) has a beta value of 1.54 and has seen 4.51 million shares traded in the last trading session. The company, currently
TransCode Therapeutics Inc (NASDAQ:RNAZ) has a beta value of 1.45 and has seen 22.79 million shares traded in the last trading session. The company, currently
During the last session, TransCode Therapeutics Inc (NASDAQ:RNAZ)’s traded shares were 3.4 million, with the beta value of the company hitting 1.42. At the end
During the recent session, TransCode Therapeutics Inc (NASDAQ:RNAZ)’s traded shares were 1.52 million, with the beta value of the company hitting 1.42. At the last
In the last trading session, 16.96 million shares of the TransCode Therapeutics Inc (NASDAQ:RNAZ) were traded, and its beta was 1.30. Most recently the company’s
In the last trading session, 215.36 million shares of the TransCode Therapeutics Inc (NASDAQ:RNAZ) were traded, and its beta was 1.40. Most recently the company’s
TransCode Therapeutics Inc (NASDAQ:RNAZ)’s traded shares stood at 1.06 million during the last session, with the company’s beta value hitting 1.42. At the close of
In the latest trading session, 0.7 million TransCode Therapeutics Inc (NASDAQ:RNAZ) shares changed hands as the company’s beta touched 1.41. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
